Jamia Hamdard

What is the average package at Jamia Hamdard?

The average package at Jamia Hamdard, New Delhi for the 2025 placement season was ₹5.50 LPA at the undergraduate level, with the highest package touching ₹31 LPA (₹31,00,000) and an overall placement rate of 72%. Postgraduate cohorts averaged a higher ₹6.80 LPA in 2025. The ₹31 LPA peak was offered to two BTech CSE graduates recruited by Deloitte, while a separate MBA (Healthcare) student secured the top PG offer of around ₹20 LPA. Jamia Hamdard is a deemed-to-be university best known for pharmacy, where it holds NIRF 2025 Pharmacy Rank 1 (score 86.59), and that pharma-health-IT mix shapes its salary outcomes across schools.

Branch/Course-Wise Package Breakdown

This table breaks down the 2025 Jamia Hamdard placement packages by branch and course so an aspirant can see which programme earns the most. It answers the question "which Jamia Hamdard course pays best?" by listing the average, median and highest CTC per stream. Median figures are drawn from the institution's reported 2025 drive and the NIRF disclosures; where a programme-specific average was not separately published, the median is the most reliable central figure and the highest reflects the top offer made to that stream. Read it stream-by-stream rather than as a single university number, because pharmacy, engineering and management diverge sharply at Jamia Hamdard.

The takeaway for Jamia Hamdard applicants is that postgraduate pharmacy and management lead on median pay, with MPharm at ₹7.35 LPA (2024) and MBA Healthcare reaching ₹20 LPA at the top. BTech CSE delivers the single highest figure (₹31 LPA at Deloitte), but its median of ₹5.90 LPA in 2025 sits close to BPharm. ECE trails its CSE counterpart, a normal pattern at a pharma-first deemed university where IT recruiters concentrate on computer science. If you are choosing a stream for earnings, MPharm, MCA and MBA offer the strongest median outcomes at Jamia Hamdard.

Year-Wise Package Trend

This table charts how Jamia Hamdard's headline packages have moved across recent years so you can judge whether outcomes are improving. It answers "is the Jamia Hamdard average package rising?" by placing the undergraduate average, median and highest side by side. The 2025 average of ₹5.50 LPA is the institution's reported figure, up roughly 8% from the ₹5.10 LPA UG median in 2024; note that a formal university-wide average was not separately disclosed for 2024, so its average cell is marked as not disclosed while the highest (₹31 LPA) carried over. Read the median column for the most stable year-on-year comparison.

The trajectory is upward but measured: the BTech-led UG median rose from ₹4.87 LPA in 2023 to ₹5.10 LPA in 2024 and the reported average reached ₹5.50 LPA in 2025, alongside a placement-rate jump from 67% in 2024 to 72% in 2025. The ₹31 LPA ceiling held steady across 2024 and 2025, signalling a stable top-tier recruiter base (Deloitte, Sun Pharma, KPMG) rather than a sudden spike. For an applicant, Jamia Hamdard's value is in the rising median and broadening placement coverage, not in chasing the rare ₹31 LPA outlier.

Notable Offers & Package Distribution

Jamia Hamdard's top offer in 2025 was ₹31 LPA, secured by two BTech CSE students at Deloitte, while MBA (Healthcare) topped the postgraduate table at around ₹20 LPA and pharmacy graduates from the School of Pharmaceutical Education and Research (SPER) recorded offers ranging from ₹3 LPA to ₹26 LPA. More than 150 companies visited the campus during the 2025 cycle, with high-volume recruiters including TCS (around 45 students), KPMG (around 28 students) and Sun Pharma (around 20 students), supported by Deloitte, Infosys, HCL Technologies, Pfizer and HDFC Bank.

The distribution at Jamia Hamdard is bimodal, reflecting its identity as a deemed university anchored in health sciences. The bulk of offers cluster in the ₹3 LPA to ₹6 LPA mass-recruiter band: the School of Nursing Sciences and Allied Health (SNSAH) placed 99 students between ₹3 LPA and ₹6 LPA, and the School of Chemical and Life Sciences (SCLS) placed 29 students between ₹2.5 LPA and ₹4.5 LPA in the 2024-2025 window. A smaller premium tier (₹14 LPA to ₹31 LPA) is driven by Deloitte and consulting/IT roles for CSE and by specialist pharma R&D roles for MPharm and SPER graduates. For an aspirant, this means a realistic expectation around the ₹5 LPA to ₹6 LPA median, with genuine but selective upside above ₹20 LPA.